Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Kadayifci

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Endoscopy|January 23, 2008
Risk factors for post-ERCP pancreatitisA Kadayifci
Panminerva Medica|March 3, 2010
Metabolic syndrome and liver transplantationA Kadayifci
Journal of Internal Medicine|August 1, 1995
Absence of circulating antineutrophil cytoplasmic antibodies in familial Mediterranean feverH Simsek, A Kadayifci
The American Journal of Gastroenterology|June 1, 1996
Should omeprazole be used for the treatment and prevention of duodenal ulcer as a monotherapeutic agent?A Kadayifci, G Oksüzöğlu
The Journal of International Medical Research|May 1, 1996
Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapyH Simsek, A Kadayifci
The American Journal of Gastroenterology|October 1, 1995
Do Helicobacter pylori-positive duodenal ulcers have an increased risk of bleeding?A Kadayifci, H Simsek
International Journal of Clinical Practice|February 29, 2000
Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppressionY Kepekci, A Kadayifci
International Journal of Clinical Pharmacology and Therapeutics|July 8, 1999
Fixed drug eruption in hands caused by omeprazoleY Kepekci, A Kadayifci
European Journal of Haematology|May 1, 1996
Epinephrine injection therapy for peptic ulcer bleeding in hemophilia patientsA Kadayifci, H Simsek
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Importance of serum CA 125 levels in malignant peritoneal mesotheliomaH Simsek, A Kadayifci, E Okan
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Endoscopy|January 23, 2008
Risk factors for post-ERCP pancreatitisA Kadayifci
Panminerva Medica|March 3, 2010
Metabolic syndrome and liver transplantationA Kadayifci
Journal of Internal Medicine|August 1, 1995
Absence of circulating antineutrophil cytoplasmic antibodies in familial Mediterranean feverH Simsek, A Kadayifci
The American Journal of Gastroenterology|June 1, 1996
Should omeprazole be used for the treatment and prevention of duodenal ulcer as a monotherapeutic agent?A Kadayifci, G Oksüzöğlu
The Journal of International Medical Research|May 1, 1996
Serum interleukin 2 and soluble interleukin 2 receptor in chronic active hepatitis C: effect of interferon therapyH Simsek, A Kadayifci
The American Journal of Gastroenterology|October 1, 1995
Do Helicobacter pylori-positive duodenal ulcers have an increased risk of bleeding?A Kadayifci, H Simsek
International Journal of Clinical Practice|February 29, 2000
Does the eradication of Helicobacter pylori cure duodenal ulcer disease in communities with a high prevalence rate? Comparison with long-term acid suppressionY Kepekci, A Kadayifci
International Journal of Clinical Pharmacology and Therapeutics|July 8, 1999
Fixed drug eruption in hands caused by omeprazoleY Kepekci, A Kadayifci
European Journal of Haematology|May 1, 1996
Epinephrine injection therapy for peptic ulcer bleeding in hemophilia patientsA Kadayifci, H Simsek
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|January 1, 1996
Importance of serum CA 125 levels in malignant peritoneal mesotheliomaH Simsek, A Kadayifci, E Okan
Pageof 6